13F Holdings
中文EN

SCND SCIENTIFIC INDUSTRIES INC

Laboratory Analytical Instruments · OTC · SEC CIK 87802 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.6%
TTM net income YoY-244.6%
TTM EPS YoY-208.3%
Revenue 3-yr CAGR-19.6%
Net income 3-yr CAGR—

Margins

Gross margin31.3%
Operating margin-116.3%
Net margin-75.1%
FCF margin-110.6%
EBITDA margin-110.8%

Returns

ROE-40.4%
ROA-33.5%
ROIC (approx.)-56.1%
Asset turnover0.45x

Leverage & solvency

Liabilities / assets20.7%
Debt / equity0.00x
Current ratio6.43x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.46x
Accruals ratio15.4%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-06-30FY20202021-06-30
Income statement
Revenue$5.05M$4.80M$11.11M$11.40M$9.78M
Cost of revenue$3.75M$2.79M$6.01M$5.66M$4.80M
Gross profit$1.30M$2.01M$5.10M$5.74M$4.98M
R&D expense$2.49M$2.90M$3.57M$2.87M$1.62M
SG&A expense$3.27M$4.12M$5.42M$5.82M$4.03M
Operating income-$7.89M-$8.22M-$9.26M-$11.54M-$4.71M
Pretax income-$1.78M-$8.02M-$9.09M-$11.28M-$4.05M
Income tax$4,600$0$0$2.39M-$1.15M
Net income-$1.22M-$6.45M-$9.09M-$13.67M-$3.67M
EBITDA-$7.28M-$7.47M-$8.51M-$10.86M-$4.46M
EPS (basic)————-1.00
EPS (diluted)-0.11-0.61-1.27—-1.00
Weighted avg. shares (diluted)11.34M10.50M10.15M6.64M3.19M
Banking
Provision for credit losses——$0$0$4,000
Balance sheet
Cash & equivalents$955,000$587,900$796,100$2.97M$9.68M
Short-term investments$5.71M————
Receivables$865,800$581,900$1.16M$1.50M$1.29M
Inventory$1.75M$2.06M$4.88M$4.70M$2.98M
Current assets$10.39M$8.29M$12.34M$16.27M$18.43M
PP&E, net$690,900$796,300$1.08M$1.01M$412,600
Goodwill$115,300$115,300$115,300$115,300$4.40M
Intangibles$103,500$752,300$1.25M$2.08M$2.56M
Total assets$12.61M$11.56M$16.73M$21.01M$29.01M
Current liabilities$1.35M$1.75M$1.84M$2.23M$2.29M
Total liabilities$1.94M$2.44M$2.85M$3.47M$2.78M
Shareholders' equity$10.66M$9.12M$13.89M$17.54M$26.22M
Shares outstanding11.93M10.50M10.15M7.00M6.46M
Cash flow statement
Operating cash flow-$8.15M-$3.05M-$6.16M-$5.19M-$3.58M
Capital expenditure$63,200$98,900$131,700$757,600$198,700
Free cash flow-$8.21M-$3.15M-$6.29M-$5.95M-$3.78M
Investing cash flow$3.83M$2.87M-$735,100-$3.75M-$10.88M
Financing cash flow$1.95M$645,700$5.75M$2.31M$16.59M
Depreciation & amortization$610,000$750,700$754,000$688,200$251,500
Stock-based compensation$520,700$1.17M$2.24M$2.35M$2.11M

Free plan shows the latest 5 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.